Teen girls can skip Pap tests, according to new guidelines that say women should start cervical cancer screening at age 21. But some experts are concerned that rates of sexually transmitted diseases or unplanned pregnancies could increase without the Pap test to prompt a doctor's visit.
Young women should have their first Pap test no sooner than age 21, regardless of when they become sexually active, say new guidelines from the American College of Obstetricians and Gynecologists. Earlier screening for cervical cancer may lead to unnecessary and possibly harmful treatments for an increasingly rare cancer, according to ACOG, the leading U.S. professional organization for obstetricians and gynecologists.
The Food and Drug Administration approved a second vaccine intended to protect against cervical cancer.
The death of a 14-year-old girl in England after she received a vaccination for Human Papilloma virus (HPV) has prompted a widespread freeze on the country's national vaccination program.
Boys may soon be able to get Gardasil, the vaccine given to girls and young women to prevent infection by four types of human papillomavirus.
One in four American girls ages 13 to 17 have been given at least one shot of Gardasil, the human papillomavirus vaccine that is heavily marketed as a way to prevent cervical cancer.
When Raffi Darrow brought in her two daughters, Wendy and Alice, for their annual back-to-school checkups this week, for the first time in her career as a mom, Darrow decided to be a rebel.
Is Gardasil vaccination reliable? I've heard plenty of ugly things about this vaccination. I have a 17-year-old daughter and her doctor recommends that she get this vaccine. I am very confused because of the negative and positive information. Would you be able to clarify?
Men who are circumcised are less likely to get sexually transmitted infections such as genital herpes and human papillomavirus (HPV), but not syphilis, according to a study of adult African men published this week in the New England Journal of Medicine.
A new British study has discovered that the highest rates of cervical cancer are found in some of London's most deprived areas.
Teen girls can skip Pap tests, according to new guidelines that say women should start cervical cancer screening at age 21. But some experts are concerned that rates of sexually transmitted diseases or unplanned pregnancies could increase without the Pap test to prompt a doctor's visit.
Young women should have their first Pap test no sooner than age 21, regardless of when they become sexually active, say new guidelines from the American College of Obstetricians and Gynecologists. Earlier screening for cervical cancer may lead to unnecessary and possibly harmful treatments for an increasingly rare cancer, according to ACOG, the leading U.S. professional organization for obstetricians and gynecologists.
The Food and Drug Administration approved a second vaccine intended to protect against cervical cancer.
The death of a 14-year-old girl in England after she received a vaccination for Human Papilloma virus (HPV) has prompted a widespread freeze on the country's national vaccination program.
Boys may soon be able to get Gardasil, the vaccine given to girls and young women to prevent infection by four types of human papillomavirus.
One in four American girls ages 13 to 17 have been given at least one shot of Gardasil, the human papillomavirus vaccine that is heavily marketed as a way to prevent cervical cancer.
When Raffi Darrow brought in her two daughters, Wendy and Alice, for their annual back-to-school checkups this week, for the first time in her career as a mom, Darrow decided to be a rebel.
Is Gardasil vaccination reliable? I've heard plenty of ugly things about this vaccination. I have a 17-year-old daughter and her doctor recommends that she get this vaccine. I am very confused because of the negative and positive information. Would you be able to clarify?
Men who are circumcised are less likely to get sexually transmitted infections such as genital herpes and human papillomavirus (HPV), but not syphilis, according to a study of adult African men published this week in the New England Journal of Medicine.
A new British study has discovered that the highest rates of cervical cancer are found in some of London's most deprived areas.
A staggering 99 percent of all cervical cancers are caused by the human papillomavirus (HPV), according to the American Cancer Society. For 50 years, the Pap test has been the gold standard for detecting cervical cancer. But there's a new kid on the block: the HPV DNA test.
Genital human papillomavirus, or HPV, which infects the skin and mucous membranes, is the most common sexually transmitted disease. About 20 million Americans have the virus, according to the Centers for Disease Control and Prevention. HPV is the major cause of cervical cancer, which kills about 250,000 women worldwide each year. In the United States, cervical cancer will be diagnosed in about 12,000 women this year, and 4,000 will die, the CDC says. Women get Pap smears to detect cervical cancer and now have the option of preventing it with a vaccine. Gardasil, developed by Merck, works to protect against four strains of HPV, including two connected to 70 percent of cervical cancers.
About one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported Thursday.
Three European scientists shared the 2008 Nobel Prize in medicine for separate discoveries of viruses that cause AIDS and cervical cancer
For 20 years, the warts studding Dede Kosawa's hands and feet multiplied and sprouted like gnarled roots.
The cervical cancer vaccine Gardasil also works to prevent cancers of the vagina and vulva, federal health officials said Friday, as they approved expanding its use to protect against those diseases as well
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report
A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.
Merck's drug against HPV has been a boon to the company but is facing growing grass-roots opposition
I'm the mother of two daughters, a teen and a tween. So every day, I tiptoe through hormonally laced minefields hoping to avoid emotional carnage in response to any of my random comments or actions.
Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said the vaccine's maker GlaxoSmithKline on Monday.
The FDA has approved the vaccine only for girls and women up to age 26. Now a medical debate is raging over whether older women should get it too
Men should be vaccinated against a sexually transmitted wart virus to protect them against a type of mouth and throat cancer, U.S. researchers said Monday.
TThe drug helps protect teenage girls from the virus that can cause cervical cancer, but a new study shows it does little to help women who already are already infected
The French government has agreed to subsidize a cervical cancer vaccine made by Merck for teenage girls and young women, according to Merck's marketing partner, French drugmaker Sanofi-Aventis.
CEOs reveal the business strategies that put companies like Akamai, Netflix, and Priceline at the top of Business 2.0's ranking of the 100 fastest-growing technology companies.
GlaxoSmithKline said it submitted an application for its cervical cancer vaccine Cervarix to the Food and Drug Administration, bringing it one step closer to challenging Merck's now-dominant Gardasil.
GlaxoSmithKline is getting closer to launching its challenge against Merck's monopoly on cervical cancer vaccines.
The Food and Drug Administration approved GlaxoSmithKline's breast cancer drug Tykerb, the drug company said Tuesday.
When John got divorced after 12 years of marriage, he took a deep breath and launched into the dating scene.
The British drugmaker GlaxoSmithKline fired a shot over Merck's bow on Thursday, by launching a study comparing its own experimental vaccine for cervical cancer to Merck's Gardasil.
The U.S. Food and Drug Administration on Thursday approved the first vaccine for cervical cancer -- Gardasil, manufactured by Merck and Co.
Federal regulators approved Gardasil, the first vaccine meant to prevent cervical cancer, the drugmaker Merck said Thursday.
Vital protection against cervical cancer could soon be made available, not just from Merck but also from GlaxoSmithKline, providing life-saving potential for women while feeding a competitive atmosphere for the drug giants.
Merck has already angered Christian conservatives by pushing to make its yet-to-be approved cervical cancer vaccine, Gardasil, mandatory for girls as young as nine. But that could be the least of the company's worries regarding the projected $4 billion-a-year vaccine.
An FDA advisory committee recommended for approval Merck's experimental cervical cancer vaccine Gardasil, said Merck and the agency.
Merck needs a hit, and it just might be on the verge of getting one, thanks to some delicate footwork with the religious right.
Merck reported strong first-quarter profit Thursday, beating consensus projections on a slight increase in sales, and prompting the drugmaker to ramp up its earnings projection for the full year despite the imminent patent loss of its top-selling product, Zocor.
Merck burned through nearly $300 million in 2005 defending itself against Vioxx-related lawsuits and shoring up its legal defenses against future cases, said CEO Richard Clark.
Merck's big problem in 2006 isn't just Vioxx. It's Zocor.
Merck, the second-biggest American drug maker, said on Friday that its experimental cervical cancer vaccine Gardasil can also prevent external genital lesions in women, including vaginal and vulvar lesions.
Eliav Barr has popped the champagne. After a decade of development, his team at Merck has just finished presenting the clinical-trial results on the company's cervical cancer vaccine, Gardasil, to ...
Researchers with Merck & Co. report they have been successful at blocking viruses that cause cervical cancer and lesions that become cancerous. About 20 million Americans are living with the virus.
HEART AND CARDIOVASCULAR
A cervical cancer vaccine that analysts are calling the biggest potential blockbuster in Merck & Co.'s pipeline passed the first phase in late-stage testing and will be filed with the Food and Drug Administration this year, the company said Thursday.
Few medical topics get as much scary press as genetic testing. The typical story: A person learns from a DNA test that he's inherited a faulty gene predisposing him to, say, a fatal brain disease y...
| Most Viewed | Most Emailed | Top Searches |
© 2010 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
